Chemical Compound
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir
CAS Registry Number
518048-05-0
Primary record
4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir
- 库存
- 9,007 克
- 纯度
- 98.7 %
- CAS
- 518048-05-0
化合物标识与属性
- CAS
- 518048-05-0
- PubChem CID
- 54671008
- SMILES
- CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
- Canonical SMILES
- Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1
名称与同义词
- Raltegravir
- Isentress
- 518048-05-0
- raltegravirum
- Raltegravir (MK-0518)
- MK-0518
- Isentress(TM)
- Raltegravir?
- Raltegravir potassium
- N-oleoyl glycine
- Raltegravir (INN)
- Raltegravir [USAN]
- Raltegravir [USAN:INN]
- RefChem:55964
- MK0518
- Raltegravir [INN:BAN]
- RALTEGRAVIR [MI]
- RALTEGRAVIR [INN]
- Raltegravir(MK-0518)
- Raltegravir; MK-0518
- Raltegravir Potassium Salt
- DTXSID2048660
- CHEBI:82960
- D0I1FQ
- Epitope ID:231726
- RALTEGRAVIR [VANDF]
- UNII-22VKV8053U
- Raltegravir - MK-0518
- Raltegravir(MK-0518)/
- 22VKV8053U
- RALTEGRAVIR [MART.]
- hydropyrimidine-4-carboxamide
- SCHEMBL51817
- DTXCID5028586
- RALTEGRAVIR [WHO-DD]
- C20H21FN6O5
- cc-110
- HSDB 8124
- MLS006011985
- (2-Methoxy-phenyl)-hydrazine
- SCHEMBL996804
- MK 0518
- MFCD10698872
- RALTEGRAVIR [EMA EPAR]
- CHEMBL254316
- orb1305950
- SCHEMBL2112870
- Raltegravir - Bio-X trade mark
- BDBM25351
- GTPL11571
- KS-00000XJN
- J05AX08
- CZFFBEXEKNGXKS-UHFFFAOYSA-N
- BCPP000093
- GLXC-90212
- HMS3655B09
- HMS5080N13
- 518048-05-0 (free)
- AOB87131
- BCP01394
- EX-A2147
- Tox21_113019
- ABP000913
- EBC-07544
- MFCD12031642
- MK-518
- NCGC00184997-01
- NSC762522
- s2005
- ZINC13831130
- N-(2-(4-(4-fluorobenzylcarbamoyl)
- AKOS015902444
- AKOS025149884
- AKOS032960305
- N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
- Tox21_113019_1
- ZINC114994525
- AC-5261
- ACN-046772
- AN-3529
- CCG-269170
- CS-2396
- CS-O-11731
- DB06817
- FR29048
- NSC-762522
- PB13312
- SB20935
- 871038-72-1
- CID11598201
- CID11700929
- NCGC00274066-01
- NCGC00274066-05
- 0518, MK
- AK326327
- AS-16992
- BC228658
- BR164312
- CJ-14473
- HY-10353
- SC-69059
- SMR003601806
- K-0518
- AB0028054
- AB1004864
- TL8006542
- 2450A
- A4073
- CAS-518048-05-0
- FT-0649660
- L000900612
- NS00015450
- SW220138-1
- X0050
- J2.509.696G
- L-000900612
- D06676
- D07133
- EN300-120882
- MK-0518;MK 0518;MK0518
- Q-4458
- yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- AB01566833_01
- N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- 038R721
- 048R050
- A828788
- Q421552
- 4-Pyrimidinecarboxamide, N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-
- I14-1973
- N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- BRD-K05658747-001-02-9
- BRD-K05658747-001-03-7
- BRD-K05658747-237-01-1
- [(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-
- N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
- N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-
- Z1532717445
- N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide
- RAL
- 871038-72-1, Isentress, Raltegravir potassium, MK-518, D07133
- N-[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- RGV
- 4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-; N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide; 5-Hydroxy-2-[1-[[(5-Methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]-1-methylethyl]-N-(4-fluorobenzyl)-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide; N-(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; RAL; Raltegravir
- N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo -4-pyrimidinecarboxamide
- N-(2-(4-((4-fluorophenyl)methylcarbamoyl)-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
- N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl) -5-methyl-1,3,4-oxadiazole-2- carboxamide
- N-(2-(4-(4-FLUOROBENZYLCARBAMOYL)-5-HYDROXY-1-METHYL-6-OXO-1,6- DIHYDROPYRIMIDIN-2-YL)PROPAN-2-YL)-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE
- N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-OH-1-Me-6-oxo-pyrimidin-2-yl)propan-2-yl)-5-Me-1,3,4-oxadiazole-2-carboxamide
- N-(4-Fluorobenzyl)-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-yl)carbonylamino]ethyl]-6-oxo-4-pyrimidinecarboxamide
- N-(4-Fluorobenzyl)-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazole-2-yl)carbonylamino]ethyl]-6-oxopyrimidine-4-carboxamide
- N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE
- N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di
- N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di hydropyrimidine-4-carboxamide
- N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- N-[(4-Fluorophenyl)methyl]-5-hydroxy-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide
- N-[1-[(4Z)-4-[[(4-fluorophenyl)methylamino]-hydroxy-methylene]-1-methyl-5,6-dioxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- N-[2-(4-{[(4-fluorophenyl)methyl]carbamoyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- N-{2-[(4Z)-4-({[(4-FLUOROPHENYL)METHYL]AMINO}(HYDROXY)METHYLIDENE)-1-METHYL-5,6-DIOXOPYRIMIDIN-2-YL]PROPAN-2-YL}-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE
- RLT